OMEPRAL Side Effects

6967453-6 | Long Qt Syndrome
on Aug 26, 2010 Male patient from JAPAN , 80 years of age, weighting 94.80 lb, was diagnosed with reflux oesophagitis, hypothyroidism, diabetes mellitus, rheumatoid arthritis (What is rheumatoid arthritis?), angina pectoris, hypertension and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: long qt syndrome. Omepral dosage: . During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), BASEN OD (View Basen Od Review and Basen Od Label ), VANCOMIC (View Vancomic Review and Vancomic Label ), RIMATIL (View Rimatil Review and Rimatil Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), DILAZEP HYDROCHLORIDE (View Dilazep Hydrochloride Review and Dilazep Hydrochloride Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ). Patient was hospitalized.

6944747-1 | Cardiac Failure, Hypertension, Long Qt Syndrome, Pleural Effusion, Pulmonary Oedema
Patient was taking Omepral (View Usage). Patient had the following side effects: cardiac failure, hypertension, long qt syndrome, pleural effusion, pulmonary oedema on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, weighting 94.80 lb, was diagnosed with reflux oesophagitis, hypothyroidism, diabetes mellitus, rheumatoid arthritis (What is rheumatoid arthritis?), angina pectoris, hypertension and. Omepral dosage: . During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), BASEN OD (View Basen Od Review and Basen Od Label ), VANCOMIC (View Vancomic Review and Vancomic Label ), RIMATIL (View Rimatil Review and Rimatil Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), DILAZEP HYDROCHLORIDE (View Dilazep Hydrochloride Review and Dilazep Hydrochloride Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ). Patient was hospitalized.

6895146-2 | Colitis Collagenous
Adverse event was reported on Jul 23, 2010 by a Male patient taking Omepral (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, After Omepral was administered, patient had the following side effects: colitis collagenous. During the same period patient was treated with SELOKEN (View Seloken Review and Seloken Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LUPRAC (View Luprac Review and Luprac Label ), RENIVACE (View Renivace Review and Renivace Label ), CRESTOR (View Crestor Review and Crestor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HARNAL (View Harnal Review and Harnal Label ). Patient was hospitalized.

6882513-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Liver Injury, Renal Failure Acute, Troponin T Increased
on Jul 20, 2010 Male patient from AUSTRALIA , 82 years of age, was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, liver injury, renal failure acute, troponin t increased. Omepral dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), CARDIPRIN (100) (View Cardiprin Review and Cardiprin Label ), KARVEZIDE (150/12.5) (View Karvezide Review and Karvezide Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), PRAZOSIN HYDROCHLORIDE (View Prazosin Hydrochloride Review and Prazosin Hydrochloride Label ), PROGOUT (View Progout Review and Progout Label ), SAW PALMETTO (View Saw Palmetto Review and Saw Palmetto Label ). Patient was hospitalized.


6875889-7 | Colitis Collagenous
on Jul 16, 2010 Female patient from JAPAN , 82 years of age, weighting 88.18 lb, was diagnosed with reflux oesophagitis and was treated with Omepral (View Usage). Patient had the following side effects: colitis collagenous. Omepral dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FLUITRAN (View Fluitran Review and Fluitran Label ). Patient was hospitalized.

6843440-3 | Colitis Collagenous
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: colitis collagenous on Jul 06, 2010 from JAPAN Additional patient health information: Female patient , 82 years of age, weighting 88.18 lb, was diagnosed with reflux oesophagitis and. Omepral dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (View Blopress Review and Blopress Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FLUITRAN (View Fluitran Review and Fluitran Label ). Patient was hospitalized.

6816769-2 | Colitis Collagenous
Adverse event was reported on Jun 28, 2010 by a Male patient taking Omepral (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: colitis collagenous. Patient was hospitalized.

6809417-9 | Accommodation Disorder
on Jun 22, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with reflux oesophagitis and was treated with Omepral (View Usage). Patient had the following side effects: accommodation disorder. Omepral dosage: .

6785991-6 | Renal Failure
on Jun 15, 2010 Male patient from JAPAN , 75 years of age, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: renal failure. Omepral dosage: .

6774123-6 | Ageusia, Atrophic Glossitis, Dry Mouth, Skin Exfoliation, Stomatitis, Thirst
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, atrophic glossitis, dry mouth, skin exfoliation, stomatitis, thirst on Jun 08, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, weighting 158.7 lb, was diagnosed with gastric ulcer, gastritis and. Omepral dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), SAWACILLIN (View Sawacillin Review and Sawacillin Label ), CLARITH (View Clarith Review and Clarith Label ).

6763873-3 | Ageusia, Atrophic Glossitis, Dry Mouth, Skin Exfoliation, Stomatitis, Thirst
Adverse event was reported on Jun 01, 2010 by a Male patient taking Omepral (View Usage) (Dosage: ) was diagnosed with gastric ulcer, gastritis and. Location: JAPAN , 60 years of age, weighting 158.7 lb, Patient had the following side effects: ageusia, atrophic glossitis, dry mouth, skin exfoliation, stomatitis, thirst. During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), SAWACILLIN (View Sawacillin Review and Sawacillin Label ), CLARITH (View Clarith Review and Clarith Label ).

6755801-1 | Clostridium Difficile Colitis
on May 28, 2010 Male patient from JAPAN , 90 years of age, weighting 92.59 lb, was diagnosed with gastric ulcer haemorrhage and was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: clostridium difficile colitis. Omepral dosage: . During the same period patient was treated with GLUCOSE (Total 200 Ml With Neoamiyu (amino Acid Preparations For Renal Insufficiency) On The Day Of Dialysis) (View Glucose Review and Glucose Label ), NEOAMIYU (Total 200 Ml With 50 % Glucose Solution On The Day Of Dialysis) (View Neoamiyu Review and Neoamiyu Label ). Patient was hospitalized.

6743302-6 | Accommodation Disorder
on May 18, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with reflux oesophagitis and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: accommodation disorder. Omepral dosage: .

6688179-2 | Blood Triglycerides Increased
Patient was taking Omepral (View Usage). Patient had the following side effects: blood triglycerides increased on Apr 15, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with reflux oesophagitis and. Omepral dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6645454-5 | Urticaria
Adverse event was reported on Mar 12, 2010 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with helicobacter infection, cerebral infarction, hypertension and. Location: JAPAN , 72 years of age, After Omepral was administered, patient had the following side effects: urticaria. During the same period patient was treated with CLARITH (View Clarith Review and Clarith Label ), PASETOCIN (View Pasetocin Review and Pasetocin Label ), DOVONEX (View Dovonex Review and Dovonex Label ), NERISONA (View Nerisona Review and Nerisona Label ), METHADERM (View Methaderm Review and Methaderm Label ), SAHNE (View Sahne Review and Sahne Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6622766-2 | Jaundice, Liver Disorder
on Mar 02, 2010 Male patient from JAPAN , 51 years of age, was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), liver disorder. Omepral dosage: . Patient was hospitalized.

6615146-7 | Eczema
on Feb 26, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with helicobacter infection and was treated with Omepral (View Usage). Patient had the following side effects: eczema (What is eczema?). Omepral dosage: . During the same period patient was treated with CLARITH (View Clarith Review and Clarith Label ), PASETOCIN (View Pasetocin Review and Pasetocin Label ), DOVONEX (View Dovonex Review and Dovonex Label ), NERISONA (View Nerisona Review and Nerisona Label ), METHADERM (View Methaderm Review and Methaderm Label ), SAHNE (View Sahne Review and Sahne Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6611409-X | Colitis Collagenous
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: colitis collagenous on Feb 26, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with reflux oesophagitis and. Omepral dosage: . During the same period patient was treated with VASOLAN (View Vasolan Review and Vasolan Label ), PIMENOL (View Pimenol Review and Pimenol Label ). Patient was hospitalized.

6594588-2 | Granulocytopenia
Adverse event was reported on Feb 15, 2010 by a Male patient taking Omepral (View Usage) (Dosage: ) . Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: granulocytopenia. During the same period patient was treated with OMEPRAL INJECTION (View Omepral Injection Review and Omepral Injection Label ). Patient was hospitalized.

6582547-5 | Jaundice, Liver Disorder
on Feb 08, 2010 Male patient from JAPAN , 51 years of age, was treated with Omepral (View Usage). Patient had the following side effects: jaundice (What is jaundice?), liver disorder. Omepral dosage: . Patient was hospitalized.

6581633-3 | Colitis Collagenous
on Feb 05, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with reflux oesophagitis and was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: colitis collagenous. Omepral dosage: . During the same period patient was treated with VASOLAN (View Vasolan Review and Vasolan Label ), PIMENOL (View Pimenol Review and Pimenol Label ). Patient was hospitalized.

6581000-2 | Granulocytopenia
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia on Feb 04, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, . Omepral dosage: . During the same period patient was treated with OMEPRAL INJECTION (View Omepral Injection Review and Omepral Injection Label ). Patient was hospitalized.

6574055-2 | Leukocytoclastic Vasculitis
Adverse event was reported on Jan 29, 2010 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with gastric ulcer, diabetes mellitus, myocardial infarction, hyperlipidaemia, hypertension and. Location: JAPAN , 75 years of age, Patient had the following side effects: leukocytoclastic vasculitis. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), ITOROL (View Itorol Review and Itorol Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), SELBEX (View Selbex Review and Selbex Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ADALAT (View Adalat Review and Adalat Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ). Patient was hospitalized.

6549770-7 | Diarrhoea, Vomiting
on Jan 19, 2010 Female patient from JAPAN , 80 years of age, weighting 90.39 lb, was diagnosed with anastomotic ulcer, gastric cancer, diarrhoea, constipation (What is constipation?), intestinal obstruction and was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: diarrhoea, vomiting. Omepral dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), LAC B (View Lac-b Review and Lac-b Label ), BERIZYM (View Berizym Review and Berizym Label ), PURSENNID (View Pursennid Review and Pursennid Label ), MAGMITT (View Magmitt Review and Magmitt Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ).

6541772-X | Diarrhoea, Vomiting
on Jan 14, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with anastomotic ulcer and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, vomiting. Omepral dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LAC B (View Lac-b Review and Lac-b Label ).

6540242-2 | Gastroenteritis Bacterial
Patient was taking Omepral (View Usage). Patient had the following side effects: gastroenteritis bacterial on Jan 07, 2010 from JAPAN Additional patient health information: Female patient , weighting 66.14 lb, was diagnosed with reflux oesophagitis, cataract (What is cataract?), insomnia, hyperlipidaemia, gastritis, diarrhoea and. Omepral dosage: . During the same period patient was treated with FLUMETHOLON (View Flumetholon Review and Flumetholon Label ), CRAVIT (View Cravit Review and Cravit Label ), BRONUCK (View Bronuck Review and Bronuck Label ), LORAMET (View Loramet Review and Loramet Label ), LOCHOL (View Lochol Review and Lochol Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), ENTERONON R (View Enteronon-r Review and Enteronon-r Label ). Patient was hospitalized.

6519971-2 | Gastrointestinal Infection
Adverse event was reported on Dec 21, 2009 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis and. Location: JAPAN , 83 years of age, After Omepral was administered, patient had the following side effects: gastrointestinal infection. During the same period patient was treated with LENDORMIN (View Lendormin Review and Lendormin Label ), FLUMETHOLON (View Flumetholon Review and Flumetholon Label ). Patient was hospitalized.

6483835-3 | Hepatic Function Abnormal
on Dec 01, 2009 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with gastritis, hyperuricaemia, hypertension and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Omepral dosage: . During the same period patient was treated with GASTROM (View Gastrom Review and Gastrom Label ), URINORM (View Urinorm Review and Urinorm Label ), BLOPRESS (View Blopress Review and Blopress Label ), MAINTATE (View Maintate Review and Maintate Label ). Patient was hospitalized.

6483792-X | Condition Aggravated, Hepatic Function Abnormal, Hepatic Steatosis, Hepatitis B, Nodule, Pulmonary Arteriovenous Fistula
on Dec 03, 2009 Male patient from JAPAN , 45 years of age, weighting 178.6 lb, was diagnosed with duodenal ulcer, helicobacter infection, gastrointestinal disorder and was treated with Omepral (View Usage). Patient had the following side effects: condition aggravated, hepatic function abnormal, hepatic steatosis, hepatitis b (What is hepatitis b?), nodule, pulmonary arteriovenous fistula. Omepral dosage: . During the same period patient was treated with SAWACILLIN (View Sawacillin Review and Sawacillin Label ), KLARICID (View Klaricid Review and Klaricid Label ), THIATON (View Thiaton Review and Thiaton Label ), SELBEX (View Selbex Review and Selbex Label ), GASTROM (View Gastrom Review and Gastrom Label ). Patient was hospitalized.

6450082-0 | Blood Amylase Increased, Toxic Epidermal Necrolysis
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: blood amylase increased, toxic epidermal necrolysis on Nov 17, 2009 from JAPAN Additional patient health information: Male patient , 42 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, hyperuricaemia, hypertension, aneurysm (What is aneurysm?) and. Omepral dosage: . During the same period patient was treated with ANZIEF (View Anzief Review and Anzief Label ), PROPOFOL (View Propofol Review and Propofol Label ), MICARDIS (View Micardis Review and Micardis Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6447138-5 | Colitis Collagenous
Adverse event was reported on Nov 10, 2009 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis, neuralgia, autonomic nervous system imbalance, gastritis erosive, hypertension, enterocolitis, diarrhoea and. Location: JAPAN , 64 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: colitis collagenous. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), CONSTAN (View Constan Review and Constan Label ), SELBEX (View Selbex Review and Selbex Label ), MAINTATE (View Maintate Review and Maintate Label ), LAC B (View Lac-b Review and Lac-b Label ), LOPEMIN (View Lopemin Review and Lopemin Label ), PARIET (View Pariet Review and Pariet Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

6444197-0 | Pulmonary Alveolar Haemorrhage
on Nov 09, 2009 Male patient from JAPAN , 20 years of age, was treated with Omepral (View Usage). Patient had the following side effects: pulmonary alveolar haemorrhage. Omepral dosage: .

6410683-2 | Platelet Count Decreased
on Oct 19, 2009 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with abdominal pain upper, pancreatitis and was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: platelet count decreased. Omepral dosage: . During the same period patient was treated with FOIPAN (View Foipan Review and Foipan Label ).

6405473-0 | Rhabdomyolysis
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Oct 08, 2009 from JAPAN Additional patient health information: Female patient , 69 years of age, weighting 114.6 lb, was diagnosed with gastric ulcer helicobacter and. Omepral dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CERCINE (View Cercine Review and Cercine Label ), POWDER MEDICINE (View Powder Medicine Review and Powder Medicine Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DEPAS (View Depas Review and Depas Label ), MYONAL (View Myonal Review and Myonal Label ). Patient was hospitalized.

6405321-9 | Accidental Poisoning
Adverse event was reported on Oct 09, 2009 by a Male patient taking Omepral (View Usage) (Dosage: 20 Mg X 10) . Location: JAPAN , child 2 years of age, Patient had the following side effects: accidental poisoning.

6395158-1 | Agranulocytosis
on Oct 05, 2009 Male patient from JAPAN , 69 years of age, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: agranulocytosis. Omepral dosage: .

6395082-4 | Hypomagnesaemia
on Sep 30, 2009 Male patient from JAPAN , 40 years of age, was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: hypomagnesaemia. Omepral dosage: . During the same period patient was treated with CAMOSTAT MESILATE (View Camostat Mesilate Review and Camostat Mesilate Label ), URSODESOXYCHOLIC ACID (View Ursodesoxycholic Acid Review and Ursodesoxycholic Acid Label ).

6395056-3 | Rhabdomyolysis
Patient was taking Omepral (View Usage). Patient had the following side effects: rhabdomyolysis on Oct 01, 2009 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with gastric ulcer helicobacter and. Omepral dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CERCINE (View Cercine Review and Cercine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DEPAS (View Depas Review and Depas Label ), MYONAL (View Myonal Review and Myonal Label ). Patient was hospitalized.

6379852-4 | Hypokalaemia
Adverse event was reported on Sep 18, 2009 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis and. Location: JAPAN , 73 years of age, After Omepral was administered, patient had the following side effects: hypokalaemia. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), JUVELA (View Juvela Review and Juvela Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6377094-X | Lymphopenia, Oral Herpes, Skin Exfoliation
on Sep 15, 2009 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with gastritis, cervical myelopathy and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: lymphopenia, oral herpes, skin exfoliation. Omepral dosage: . During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ), TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6368319-5 | Disseminated Intravascular Coagulation, Hypoglycaemia, Jaundice
on Sep 14, 2009 Male patient from JAPAN , 78 years of age, was treated with Omepral (View Usage). Patient had the following side effects: disseminated intravascular coagulation, hypoglycaemia, jaundice (What is jaundice?). Omepral dosage: .

6354843-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased on Sep 05, 2009 from JAPAN Additional patient health information: Male patient , 45 years of age, was diagnosed with reflux oesophagitis, helicobacter infection and. Omepral dosage: . During the same period patient was treated with SAWACILLIN (View Sawacillin Review and Sawacillin Label ), KLARICID (View Klaricid Review and Klaricid Label ). Patient was hospitalized.

6347378-X | Hypokalaemia
Adverse event was reported on Sep 01, 2009 by a Female patient taking Omepral (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: hypokalaemia. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), JUVELA (View Juvela Review and Juvela Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6344561-4 | Haemorrhage Subcutaneous, Myalgia, Oedema Peripheral
on Aug 31, 2009 Male patient from JAPAN , 30 years of age, weighting 165.3 lb, was diagnosed with gastritis and was treated with Omepral (View Usage). Patient had the following side effects: haemorrhage subcutaneous, myalgia, oedema peripheral. Omepral dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), STROCAIN (View Strocain Review and Strocain Label ).

6343861-1 | Disseminated Intravascular Coagulation, Hypoglycaemia, Jaundice
on Aug 31, 2009 Male patient from JAPAN , 78 years of age, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: disseminated intravascular coagulation, hypoglycaemia, jaundice (What is jaundice?). Omepral dosage: .

6340916-2 | Interstitial Lung Disease
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Aug 31, 2009 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with reflux oesophagitis and. Omepral dosage: . During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), ALLORIN (View Allorin Review and Allorin Label ), HERBESSER (View Herbesser Review and Herbesser Label ), ALFAROL (View Alfarol Review and Alfarol Label ), GLAKAY (View Glakay Review and Glakay Label ), OPALMON (View Opalmon Review and Opalmon Label ), CLEANAL (View Cleanal Review and Cleanal Label ).

6336370-7 | Lymphopenia, Oral Herpes, Skin Exfoliation
Adverse event was reported on Aug 24, 2009 by a Male patient taking Omepral (View Usage) (Dosage: ) was diagnosed with gastritis, cervical myelopathy and. Location: JAPAN , weighting 136.7 lb, Patient had the following side effects: lymphopenia, oral herpes, skin exfoliation. During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ), TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6306324-5 | Granulocyte Count Decreased
on Aug 06, 2009 Female patient from JAPAN , 87 years of age, weighting 70.55 lb, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: granulocyte count decreased. Omepral dosage: . During the same period patient was treated with PICILLIBACTA (View Picillibacta Review and Picillibacta Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), TWINPAL (View Twinpal Review and Twinpal Label ), INTRALIPID 10% (View Intralipid 10% Review and Intralipid 10% Label ), SOLDEM 1 (View Soldem 1 Review and Soldem 1 Label ), SOLDEM 2 (View Soldem 2 Review and Soldem 2 Label ), ISOTONIC SODIUM CHLORIDE SOLUTION KIT (View Isotonic Sodium Chloride Solution Kit Review and Isotonic Sodium Chloride Solution Kit Label ), SEISHOKU (View Seishoku Review and Seishoku Label ). Patient was hospitalized.

6302631-0 | Shock, Shock Haemorrhagic
on Aug 05, 2009 Male patient from JAPAN , 79 years of age, was diagnosed with duodenal ulcer and was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: shock, shock haemorrhagic. Omepral dosage: .

6301287-0 | Interstitial Lung Disease
Patient was taking Omepral (View Usage). Patient had the following side effects: interstitial lung disease on Jul 30, 2009 from JAPAN Additional patient health information: Female patient , 72 years of age, weighting 116.8 lb, was diagnosed with reflux oesophagitis, insomnia, hypertension, back pain (What is back pain?), osteoporosis (What is osteoporosis?) and. Omepral dosage: . During the same period patient was treated with MEDIPEACE (View Medipeace Review and Medipeace Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), MOBIC (View Mobic Review and Mobic Label ), FOSAMAC (View Fosamac Review and Fosamac Label ), TOWARAT CR (View Towarat-cr Review and Towarat-cr Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).